MYCOFIT S 180MG TABLET

Mycofit S 180 mg tablet is an immunosuppressant with an active ingredient, Mycophenolate sodium. It falls under the inosine monophosphate dehydrogenase (IMPDH) inhibitor class. It is prescribed to avoid organ rejection in patients who have received one of their organs (such as heart, kidney, or liver transplantation). It is usually defined as a part of a treatment combination that includes other immunosuppressive medications.
The use of this drug is not recommended during pregnancy due to the possibility of miscarriage and congenital disabilities. This medication should not be used for pregnant women unless there are other alternatives and the benefits outweigh any risks. Women with reproductive potential should be advised to utilize effective contraception when using this tablet to avoid the possibility of pregnancy. Live vaccines shouldn’t be administered to a patient using Mycofit S 180mg tablet due to the decreased effectiveness of vaccines and the risk of getting ill. People taking this drug must not give blood during treatment and, at minimum, six weeks after having stopped treatment. It is a way to ensure that the drug has been completely removed from the body before donating blood.
It is usually advised not to use this medication when allergic to the drug or other components. Tell your doctor if you suffer from heart or liver disease before starting the treatment. Since this medication weakens the body’s immune system, it could increase the risk of developing skin cancer. Patients must know how to minimize their exposure to the ultraviolet (UV) radiation. Contact your physician immediately when you experience surface swelling, fever, or any other unidentified fatigue, dizziness, eyes, or skin. Eyes or eyes, vision impairment, decreased urine output, or seizures following this medication. Mycofit S 180 mg tablet is an immunosuppressive drug. It can affect the infant’s growing immune system and must be avoided while breastfeeding.